Results
1 -
10 of
14Apsel et al..
Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases, Nature Chemical Biology, 2008 Michael K. Hancock, Connie S. Lebakken, Jun Wang and Kun Bi.
Multi-pathway cellular analysis of compound selectivity, Mol. Biosyst., 2010, 6, 1834. Samuel M. Meier, Muhammad Hanif, Zenita Adhireksan, Verena Pichler, Maria Novak, Elisabeth Jirkovsky, Michael A. Jakupec, Vladimir B. Arion, Curt A. Davey, Bernhard K. Keppler and Christian G. Harting
er.
Novel metal(ii) arene 2-pyridinecarbothioamides: a rationale to orally active organometallic anticancer agents, Chem. Sci., 2013, 4, 1837. Enrico Rampazzo, Rebecca Voltan, Luca Petrizza, Nelsi Zaccheroni, Luca Prodi, Fabio Casciano, Giorgio Zauli and Paola Secchiero.
Proper design of silica nanoparticles combines high brightness, lack of cytotoxicity and efficient cell endocytosis, Nanoscale, 2013, 5, 7897. Hwang SH; Wecksler AT; Zhang G; Morisseau C; Nguyen LV; Fu SH; Hammock BD.
Synthesis and biological evaluation of sorafenib- and regorafenib-like sEH inhibitors., Bioorganic & medicinal chemistry letters Sonoshita et al.
A whole-animal platform to advance a clinical kinase inhibitor into new disease space.
Nature Chemical Biology, doi: 10.1038/nchembio.2556, published online 22 January 2018 Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances [Online], Thieme: Stuttgart, (2006)..
Sorafenib, Pharmaceutical Substances Guan Longfei, Yang Hongbin, Cai Yingchun, Sun Lixia, Di Peiwen, Li Weihua, Liu Guixia, Tang Yun.
ADMET-score – a comprehensive scoring function for evaluation of chemical drug-likeness, MedChemComm, 2019